Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boceprevir + PR in Russian HCV Genotype 1 Patients
NCT01425203Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Nov 2011
- Primary completion
- Oct 2013
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of boceprevir in hepatitis C (HCV), sponsored by Merck & Co.. Started Nov 2011; status: completed.
02
Drugs
boceprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01425203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01425203.